China SXT Pharmaceuticals...

AI Score

0

Unlock

0.38
-0.04 (-9.16%)
At close: Jan 15, 2025, 12:35 PM

Cashflow (Annual)

Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
Year FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16
Net Income -3.10M -5.93M -5.74M -2.75M -10.29M 1.54M 1.19M 1.19M 141.54K
Depreciation & Amortization 203.25K 250.16K 320.01K 345.41K 331.84K 180.92K 129.44K 99.23K 88.96K
Stock-Based Compensation 352.10K 554.57K 2.33M n/a n/a n/a n/a n/a n/a
Other Working Capital 159.41K 83.91K 1.28M -506.08K 1.50M 660.63K -467.63K 1.04M 1.09M
Other Non-Cash Items 996.69K 408.69K 1.12M 1.62M 3.35M 66.89K -2 1.44M 1.34M
Deferred Income Tax n/a 3.23M 328.15K -192.68K -101.72K -7.72K -5.85K n/a n/a
Change in Working Capital -381.56K 1.42M 1.90M -1.61M 1.95M -1.54M 608.99K -991.33K -58.63K
Operating Cash Flow -1.93M -80.76K 268.29K -1.32M 934.25K 239.19K 1.92M 293.04K 182.47K
Capital Expenditures -7.06K -70.68K -62.49K -93.04K -406.66K -610.09K -1.05M -186.31K -96.99K
Acquisitions n/a n/a n/a n/a n/a n/a n/a n/a 1.23K
Purchase of Investments n/a n/a n/a -8.85M -3.59M n/a n/a n/a n/a
Sales Maturities Of Investments n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Investing Acitivies 33.49K 58.38K 15.58K 3.13M -1.50M -11.28K -92.42K -7.13K -36.04K
Investing Cash Flow 26.42K -12.30K -46.91K -5.81M -5.50M -610.09K -1.14M -186.31K -95.76K
Debt Repayment 1.31M 4.00M 2.77M -124.95K 8.80M 69.49K -314.22K n/a n/a
Common Stock Repurchased n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies -3.93M -3.26M -4.29M 12.53M -5.78M 2.48M n/a -50.56K -128.59K
Financial Cash Flow -2.62M 2.94M 1.60M 12.41M 3.02M 9.04M -314.22K -50.56K -128.59K
Net Cash Flow -5.29M 1.80M 2.21M 6.07M -2.00M 8.63M 494.68K 54.13K -43.91K
Free Cash Flow -1.94M -151.44K 205.80K -1.41M 527.59K -370.89K 869.44K 106.73K 85.48K